261 related articles for article (PubMed ID: 35105284)
1. An Innovative Approach in Nanotechnology-based Delivery System for the Effective Management of Psoriasis.
Parveen S; Ahmed M; Baboota S; Ali J
Curr Pharm Des; 2022; 28(13):1082-1102. PubMed ID: 35105284
[TBL] [Abstract][Full Text] [Related]
2. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis.
Aziz Hazari S; Kaur H; Karwasra R; Abourehab MAS; Ali Khan A; Kesharwani P
Int J Pharm; 2023 May; 638():122938. PubMed ID: 37031809
[TBL] [Abstract][Full Text] [Related]
3. Liposome Based Drug Delivery for the Management of Psoriasis - A Comprehensive Review.
Bahadur S; Sharma M
Curr Pharm Biotechnol; 2023; 24(11):1383-1396. PubMed ID: 36518042
[TBL] [Abstract][Full Text] [Related]
4. Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis.
Saleem S; Iqubal MK; Garg S; Ali J; Baboota S
Expert Opin Drug Deliv; 2020 Jun; 17(6):817-838. PubMed ID: 32315216
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis.
Gomes GS; Frank LA; Contri RV; Longhi MS; Pohlmann AR; Guterres SS
Int J Pharm; 2023 Jan; 631():122535. PubMed ID: 36566826
[TBL] [Abstract][Full Text] [Related]
6. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
Abdelbary AA; AbouGhaly MH
Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
[TBL] [Abstract][Full Text] [Related]
7. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
Gungor S; Rezigue M
Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
[TBL] [Abstract][Full Text] [Related]
8. Insightful exploring of advanced nanocarriers for the topical/transdermal treatment of skin diseases.
El-Zaafarany GM; Nasr M
Pharm Dev Technol; 2021 Dec; 26(10):1136-1157. PubMed ID: 34751091
[TBL] [Abstract][Full Text] [Related]
9. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
Doppalapudi S; Jain A; Chopra DK; Khan W
Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
[TBL] [Abstract][Full Text] [Related]
10. Progress in novel ultradeformable vesicular drug carrier in the topical and transdermal treatment of psoriasis.
Nayak N; Somanna P; Patil AB; Radhakrishnan A
Ther Deliv; 2020 Dec; 11(12):807-819. PubMed ID: 33267650
[TBL] [Abstract][Full Text] [Related]
11. A Promising Approach of Dermal Targeting of Antipsoriatic Drugs
Tripathi D; Srivastava M; Rathour K; Rai AK; Wal P; Sahoo J; Tiwari RK; Pandey P
Drug Metab Bioanal Lett; 2023; 16(2):89-104. PubMed ID: 37534794
[TBL] [Abstract][Full Text] [Related]
12. Ethosomes as Nanocarriers for the Development of Skin Delivery Formulations.
Paiva-Santos AC; Silva AL; Guerra C; Peixoto D; Pereira-Silva M; Zeinali M; Mascarenhas-Melo F; Castro R; Veiga F
Pharm Res; 2021 Jun; 38(6):947-970. PubMed ID: 34036520
[TBL] [Abstract][Full Text] [Related]
13. Comparison of ethosomes and liposomes for skin delivery of psoralen for psoriasis therapy.
Zhang YT; Shen LN; Wu ZH; Zhao JH; Feng NP
Int J Pharm; 2014 Aug; 471(1-2):449-52. PubMed ID: 24907596
[TBL] [Abstract][Full Text] [Related]
14. Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.
Biswasroy P; Pradhan D; Kar B; Ghosh G; Rath G
AAPS PharmSciTech; 2021 May; 22(5):164. PubMed ID: 34041632
[TBL] [Abstract][Full Text] [Related]
15. Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier.
Ramanunny AK; Wadhwa S; Thakur D; Singh SK; Kumar R
Endocr Metab Immune Disord Drug Targets; 2021; 21(3):418-433. PubMed ID: 32496998
[TBL] [Abstract][Full Text] [Related]
16. Topical nanocarriers for management of Rheumatoid Arthritis: A review.
Anita C; Munira M; Mural Q; Shaily L
Biomed Pharmacother; 2021 Sep; 141():111880. PubMed ID: 34328101
[TBL] [Abstract][Full Text] [Related]
17. Exploring the potential of nanocarriers in antipsoriatic therapeutics.
Shaif M; Kushwaha P; Usmani S; Pandey S
J Dermatolog Treat; 2022 Nov; 33(7):2919-2930. PubMed ID: 35729857
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured Lipid Carriers as Potential Drug Delivery Systems for Skin Disorders.
Waghule T; Rapalli VK; Gorantla S; Saha RN; Dubey SK; Puri A; Singhvi G
Curr Pharm Des; 2020; 26(36):4569-4579. PubMed ID: 32534562
[TBL] [Abstract][Full Text] [Related]
19. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Review on Nanotechnology-Based Innovations in Topical Drug Delivery for the Treatment of Skin Cancer.
Lalotra AS; Singh V; Khurana B; Agrawal S; Shrestha S; Arora D
Curr Pharm Des; 2020; 26(44):5720-5731. PubMed ID: 32814523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
